Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38276 - 38300 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	PTGR2	145482	upregulated	entinostat results in increased expression of PTGR2 mRNA	14q24.3	A21035
Entinostat	Investigational	PTGS1	5742	upregulated	entinostat results in increased expression of PTGS1 mRNA	9q33.2	A21035
Entinostat	Investigational	PTPN21	11099	downregulated	entinostat results in decreased expression of PTPN21 mRNA	14q31	A21037
Entinostat	Investigational	PTPN3	5774	upregulated	entinostat results in increased expression of PTPN3 mRNA	9q31	A21035
Entinostat	Investigational	PTPN5	84867	downregulated	entinostat results in decreased expression of PTPN5 mRNA	11p15.1	A21037
Entinostat	Investigational	PTPRO	5800	downregulated	entinostat results in decreased expression of PTPRO mRNA	12p12.3	A21037
Entinostat	Investigational	PTX3	5806	downregulated	entinostat results in decreased expression of PTX3 mRNA	3q25.32	A21037
Entinostat	Investigational	PURG	29942	downregulated	entinostat results in decreased expression of PURG mRNA	8p12	A21037
Entinostat	Investigational	PWAR5	8123	upregulated	entinostat results in increased expression of PWAR5 mRNA	15q11.2	A21037
Entinostat	Investigational	PWAR6	100506965	upregulated	entinostat results in increased expression of PWAR6 mRNA	15q11.2	A21037
Entinostat	Investigational	PXDC1	221749	upregulated	entinostat results in increased expression of PXDC1 mRNA	6p25.2	A21037 A21035
Entinostat	Investigational	PXN-AS1	100506649	downregulated	entinostat results in decreased expression of PXN-AS1 mRNA	12q24.23	A21035
Entinostat	Investigational	PYCARD	29108	upregulated	entinostat results in increased expression of PYCARD mRNA	16p11.2	A21037
Entinostat	Investigational	PYGL	5836	upregulated	entinostat results in increased expression of PYGL mRNA	14q22.1	A21035
Entinostat	Investigational	PYROXD2	84795	upregulated	entinostat results in increased expression of PYROXD2 mRNA	10q24.2	A21035
Entinostat	Investigational	PYY	5697	upregulated	entinostat results in increased expression of PYY mRNA	17q21.31	A21037 A21035
Entinostat	Investigational	QPRT	23475	upregulated	entinostat results in increased expression of QPRT mRNA	16p11.2	A21035
Entinostat	Investigational	RAB11FIP1	80223	upregulated	entinostat results in increased expression of RAB11FIP1 mRNA	8p11.23	A21035
Entinostat	Investigational	RAB11FIP4	84440	upregulated	entinostat results in increased expression of RAB11FIP4 mRNA	17q11.2	A21037 A21035
Entinostat	Investigational	RAB17	64284	upregulated	entinostat results in increased expression of RAB17 mRNA	2q37.3	A21037
Entinostat	Investigational	RAB18	22931	downregulated	entinostat results in decreased expression of RAB18 mRNA	10p12.1	A21037
Entinostat	Investigational	RAB20	55647	upregulated	entinostat results in increased expression of RAB20 mRNA	13q34	A21037
Entinostat	Investigational	RAB23	51715	upregulated	entinostat results in increased expression of RAB23 mRNA	6p12.1-p11.2	A21035
Entinostat	Investigational	RAB27A	5873	downregulated	entinostat results in decreased expression of RAB27A mRNA	15q21.3	A21037
Entinostat	Investigational	RAB29	8934	upregulated	entinostat results in increased expression of RAB29 mRNA	1q32.1	A21037 A21035

Displaying entries 38276 - 38300 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability